Beneficial effect of intravenous iron, ferric carboxymaltose, in heart failure

被引：0
|
作者：
Paterek, A. [1 ]
Kolodziejczyk, J. [1 ]
Kepska, M. [1 ]
Mackiewicz, U. [1 ]
Maczewski, M. [1 ]
机构：
[1] Med Ctr Postgrad Educ, Dept Clin Physiol, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1966
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [1] Intravenous ferric carboxymaltose for heart failure with iron deficiency
    Coats, Andrew J. Stewart
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (01) : 134 - 135
  • [2] Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
    Ponikowski, Piotr
    van Veldhuisen, Dirk J.
    Comin-Colet, Josep
    Ertl, Georg
    Komajda, Michel
    Mareev, Viacheslav
    McDonagh, Theresa
    Parkhomenko, Alexander
    Tavazzi, Luigi
    Levesque, Victoria
    Mori, Claudio
    Roubert, Bernard
    Filippatos, Gerasimos
    Ruschitzka, Frank
    Anker, Stefan D.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (11) : 657 - 668
  • [3] Ferric Carboxymaltose in Heart Failure with Iron Deficiency
    Payan-Pernia, Salvador
    Perez-Simon, Jose Antonio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (22): : 2108 - 2110
  • [4] Ferric Carboxymaltose in Heart Failure with Iron Deficiency
    Mentz, Robert J.
    Garg, Jyotsna
    Rockhold, Frank W.
    Butler, Javed
    De Pasquale, Carmine G.
    Ezekowitz, Justin A.
    Lewis, Gregory D.
    O'Meara, Eileen
    Ponikowski, Piotr
    Troughton, Richard W.
    Wong, Yee Weng
    She, Lilin
    Harrington, Josephine
    Adamczyk, Robert
    Blackman, Nicole
    Hernandez, Adrian F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (11): : 975 - 986
  • [5] Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France
    Bourguignon, Sandrine
    Faller, Mathilde
    Champs, Francois-Olivier
    Moutier, Helene
    Levesque, Karine
    Caranhac, Gilbert
    Cohen-Solal, Alain
    [J]. ESC HEART FAILURE, 2019, 6 (03): : 559 - 569
  • [6] Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure
    Spinner, Joseph A.
    Puri, Kriti
    Powers, Jacquelyn
    Dasari, Tejasvi
    Tunuguntla, Hari
    Choudhry, Swati
    Cabrera, Antonio G.
    Shah, Mona
    Dreyer, William J.
    Denfield, Susan W.
    Price, Jack F.
    [J]. CIRCULATION, 2019, 140
  • [7] Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
    Theidel, Ulrike
    Vaatainen, Saku
    Martikainen, Janne
    Soini, Erkki
    Hardt, Thomas
    Doehner, Wolfram
    [J]. ESC HEART FAILURE, 2017, 4 (03): : 274 - 281
  • [8] Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania
    Lorenzovici, Laszlo
    Szekely, Andrea
    Farkas-Raduly, Szabolcs
    Jitaru, Ciprian
    Csanadi, Marcell
    [J]. JOURNAL OF CARDIOVASCULAR EMERGENCIES, 2019, 5 (04): : 131 - 139
  • [9] Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
    Anker, Stefan D.
    Comin Colet, Josep
    Filippatos, Gerasimos
    Willenheimer, Ronnie
    Dickstein, Kenneth
    Drexler, Helmut
    Luescher, Thomas F.
    Bart, Boris
    Banasiak, Waldemar
    Niegowska, Joanna
    Kirwan, Bridget-Anne
    Mori, Claudio
    Rothe, Barbara von Eisenhart
    Pocock, Stuart J.
    Poole-Wilson, Philip A.
    Ponikowski, Piotr
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2436 - 2448
  • [10] IV Ferric Carboxymaltose (Injectafer) for Iron Deficiency in Heart Failure
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1695): : 22 - 24
12345